Targeting L-Proline Uptake as New Strategy for Anti-chagas Drug Development.

Frontiers in Chemistry
Lucia FargnoliGuillermo Labadie

Abstract

L-Proline is an important amino acid for the pathogenic protists belonging to Trypanosoma and Leishmania genera. In Trypanosoma cruzi, the etiological agent of Chagas disease, this amino acid is involved in fundamental biological processes such as ATP production, differentiation of the insect and intracellular stages, the host cell infection and the resistance to a variety of stresses. In this study, we explore the L-Proline uptake as a chemotherapeutic target for T. cruzi. Novel inhibitors have been proposed containing the amino acid with a linker and a variable region able to block the transporter. A series of sixteen 1,2,3-triazolyl-proline derivatives have been prepared for in vitro screening against T. cruzi epimastigotes and proline uptake assays. We successfully obtained inhibitors that interfere with the amino acid internalization, which validated our design targeting the metabolite's transport. The presented structures are one of few examples of amino acid transporter inhibitors. The unprecedent application of this strategy on the development of new chemotherapy against Chagas disease, opens a new horizon on antiparasitic drug development against parasitic diseases and other pathologies.

References

Jan 1, 1976·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·D Sylvester, S M Krassner
Jan 1, 1988·Memórias do Instituto Oswaldo Cruz·V T ContrerasS Goldenberg
Sep 19, 1983·FEBS Letters·M HauptmannM Erecińska
Dec 31, 2002·The Journal of Eukaryotic Microbiology·Ariel M SilberMaria Júlia M Alves
Mar 5, 2003·Molecular and Biochemical Parasitology·Peter RohloffR Docampo
Jul 9, 2004·Cellular Microbiology·Renata R TonelliMaria Júlia M Alves
Mar 22, 2005·Current Drug Targets. Infectious Disorders·Ariel Mariano SilberClaudio Alejandro Pereira
Jul 20, 2006·Journal of the American Chemical Society·Cécile GauchetC Dale Poulter
Jul 28, 2009·Molecular and Biochemical Parasitology·Ariel M SilberMaria Júlia M Alves
Jun 19, 2010·Nature Chemical Biology·Rami N Hannoush, Jinglucy Sun
May 26, 2011·Expert Review of Anti-infective Therapy·Paulo M M GuedesJoão S Silva
Jun 3, 2011·Molecular Diversity·Guillermo R LabadieHéctor R Morbidoni
Sep 29, 2011·Chemistry, an Asian Journal·Sandip G AgalaveVandana S Pore
Aug 30, 2012·Nature Methods·Caroline A SchneiderKevin W Eliceiri
Jun 19, 2013·Journal of the American College of Cardiology·Maria Carmo Pereira NunesUNKNOWN Council on Chagas Disease of the Interamerican Society of Cardiology
Jul 31, 2013·PloS One·Lisvane Silva PaesAriel Mariano Silber
Sep 17, 2013·Neurochemistry International·Jane E CarlandRobert J Vandenberg
Sep 23, 2014·Chemistry & Biology·Craig S McKay, M G Finn
Dec 3, 2014·Bioorganic & Medicinal Chemistry Letters·Anton R HamannMargaret A L Blackie
Sep 2, 2015·The New England Journal of Medicine·Carlos A MorilloUNKNOWN BENEFIT Investigators
May 26, 2016·Journal of Bioenergetics and Biomembranes·M J BarisónA M Silber
Jul 23, 2016·Clinical Pharmacology and Therapeutics·H QosaA Kaddoumi
Mar 31, 2017·The Journal of Biological Chemistry·María Julia BarisónMaria Belen Cassera
Jul 5, 2017·Lancet·José A Pérez-Molina, Israel Molina
Aug 29, 2017·Biochimica Et Biophysica Acta. General Subjects·Melisa SayéClaudio A Pereira
Oct 11, 2017·MedChemComm·Exequiel O J PortaGuillermo R Labadie
Jul 20, 2018·MSphere·Richard M B M GirardAriel Mariano Silber

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear magnetic resonance
NMR
column chromatography
FCS
Assay

Software Mentioned

OriginPro8

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.